Brian Walsh appears to work as a company operator rather than an investor. His current public role is Chairman & Chief Executive Officer at Cagent Vascular, where the company develops next-generation angioplasty balloons using proprietary serration technology. He also previously served as President and CEO of Iantech Medical and as Head of Carl Zeiss Meditec Cataract Technology, indicating a leadership profile centered on building and commercializing medical technology businesses.